Rare diseases
Investigational molecules
Locations
Study of BMS-986340, Nivolumab, and Docetaxel for Adults with Advanced or Metastatic Cancer
GermanyStudy on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery
FinlandStudy of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors
BelgiumLow-dose nivolumab in patients with advanced cancer and high tumor mutational burden (TMB‑high)
BelgiumComparison of nivolumab drug combination versus immunotherapy‑TKI sequence in patients with metastatic renal cell carcinoma
ItalyPhase Ib/II study of momelotinib with nivolumab or pembrolizumab in unresectable stage III/IV cutaneous melanoma
SwedenStudy of immune response and biomarkers in patients with metastatic solid tumors treated with BMS-986340 and nivolumab
ItalyStudy of neoadjuvant intratumoral ipilimumab combined with systemic nivolumab in patients with locally advanced resectable oral cavity squamous cell carcinoma
The NetherlandsDurable HIV-1 control with 10-1074-LS, 3BNC117-LS and nivolumab in adults on ART: a randomized double‑blind placebo‑controlled trial
DenmarkA study to evaluate the safety and effectiveness of nivolumab and imiquimod in adults with vulvar squamous cell carcinoma
FranceCarboplatin‑based drug combination for advanced non‑small cell lung cancer patients with interstitial lung disease
FranceA study to evaluate the safety and effectiveness of PTT-4256 and nivolumab in patients with solid tumors.
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
